IC-270

N/A

Report date: 2023/02/19 20:07:58
NME

Base Information

Drug NameIC-270
Drug Alias NameIC-270
ClassificationSmall molecules
Mechanisms of ActionSpleen tyrosine kinase inhibitors
TargetsSpleen tyrosine kinase
Therapy Area/IndicationsConjunctivitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIACTA Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesZhaoke (Hong Kong) Ophthalmology Pharmaceutical LtdIACTA Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsConjunctivitis, Allergic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A